Patents by Inventor Alexander Moore

Alexander Moore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11960982
    Abstract: A system and method may partition and/or execute a NN, by, for a graph including nodes and hyper edges, each node representing a data item in the NN and each hyper edge representing an operation in the NN, identifying a deep tensor column comprising a subset of the nodes and a subset of the hyper edges, such that the operations in the deep tensor column, when executed, use only data which fits within a preselected cache.
    Type: Grant
    Filed: October 21, 2022
    Date of Patent: April 16, 2024
    Assignee: NEURALMAGIC, INC.
    Inventors: Alexander Matveev, Nir Shavit, Govind Ramnarayan, Tyler Michael Smith, Sage Moore
  • Patent number: 11954649
    Abstract: A system is provided which that allows users of electronic communication systems and/or calendar systems the ability to suggest meetings to users of different electronic communication systems and/or calendar systems via electronic messages. The system may provide users with the ability to share calendar availability with users of other electronic communication systems and/or calendar systems via electronic message. One aspect of the disclosed system is the fact that users can share interactive calendar information, and propose and confirm tentative meetings and events, with users of different electronic communications and/or calendar systems. Additionally, calendar information that is shared with others may be dynamically updated even after the electronic messages have been sent.
    Type: Grant
    Filed: April 27, 2022
    Date of Patent: April 9, 2024
    Assignee: Baydin, Inc.
    Inventors: Alexander Moore, Michael Chin, Aye Moah, Alexey Komissarouk
  • Publication number: 20240102024
    Abstract: The present disclosure provides host cells, e.g., bacterial cells, that comprise a methionine decarboxylase enzyme for the treatment of diseases and disorders associated with methionine metabolism in a subject. The disclosure further provides pharmaceutical compositions and methods of treating disorders associated with methionine metabolism, such as homocystinuria.
    Type: Application
    Filed: November 30, 2023
    Publication date: March 28, 2024
    Inventors: Dylan Alexander Carlin, Vincent M. Isabella, Jonathan McMurry, Theodore Carlton Moore, III, Mylene Perreault, Nathan Schmidt, Mark Simon
  • Publication number: 20240089185
    Abstract: Example embodiments involve a metrics collection system for collecting software usage metrics from one or more client devices at deployments. A computer, such as a server configured to execute the metrics collection system, collects software usage metrics (e.g., as a metrics submission from a client device) of the software product at the deployment, identifies a metrics type of the software usage metrics collected, assigns the software usage metrics to a metrics category, and calculates and updates a metrics score of the metrics category, based on the software usage metrics collected.
    Type: Application
    Filed: November 21, 2023
    Publication date: March 14, 2024
    Applicant: Palantir Technologies Inc.
    Inventors: Cody Moore, Yiwei Gao, Andrew Colombi, David Karesh, William Ward, Alexander Ince-Cushman, Mohammad Bukhari, Daniel Kozlowski, Jason Richardson
  • Publication number: 20240073220
    Abstract: Malicious homoglyphic domain name (MHDN) generation and associated cyber security applications are described. MHDN generation may be performed by, for example, generating, based on training data, a set of operations for use in generating the one or more potential MHDNs, wherein each operation of the set of operations may be configured to modify a base domain name according to a respective homoglyphic characteristic. The set of operations may be used to generate one or more candidate MHDN mutators. The candidate MHDN mutators may be tested for fitness values corresponding to respective likelihoods of generating an MHDN and the candidate MHDN mutators may be applied to one or more base domain names to generate potential MHDNs.
    Type: Application
    Filed: October 31, 2023
    Publication date: February 29, 2024
    Inventors: Vincent Mutolo, Alexander Chinchilli, Sean Moore, Matthew Sparrow, Connor Tess
  • Publication number: 20240071257
    Abstract: A surgeon training apparatus includes a cassette, which includes biological tissue repurposed into a form consistent with the anatomical configuration of abdominal hernias, affixed into an anatomically correct silicon framework which replicates the abdominal anatomy. The framework positions the cassette in an anatomically correct position within the abdominal cavity, enabling surgeons to train using a properly positioned representation of the target anatomy, thus requiring the surgeon to properly use surgical tools to correct the pathologic condition caused by the hernia. The cassette is formed by applying biologic tissue to a specially designed “plate,” which affixes the tissue block into the anatomic framework, and is adapted for connection to a grounding device so the surgeon can use cautery during the simulated hernia repair.
    Type: Application
    Filed: November 7, 2023
    Publication date: February 29, 2024
    Inventors: JOHN ALEXANDER, W. ANDREW GRUBBS, KAITY YU EMERSON, MORGAN DOMINICE MOORE, MEGAN HARRISION DEW, SAMUEL DAVID DREW
  • Publication number: 20240066905
    Abstract: A micro-transfer structure comprises a stamp comprising a rigid support, only a single contiguous bulk layer disposed on the rigid support, and posts disposed on the bulk layer. Components are adhered to (e.g., disposed in contact with) some but not all of the posts. The posts can be substantially identical and disposed in a regular array on the bulk layer. Each component is adhered to (e.g., in contact with) two or more posts. Components can be disposed on a source wafer entirely over sacrificial portions of a sacrificial layer on or in the source wafer and attached to anchors disposed between sacrificial portions with a tether.
    Type: Application
    Filed: November 7, 2023
    Publication date: February 29, 2024
    Inventors: Tanya Yvette Moore, David Gomez, Christopher Andrew Bower, Matthew Alexander Meitl, Salvatore Bonafede
  • Patent number: 11914957
    Abstract: Systems and methods for dynamically assessing and displaying quality features of electronic messages, while composed on client devices, can include one or more processors monitoring the process of composing the electronic message. The one or more processors can retrieve, upon detecting a pause event, data associated with the composed electronic message from a message composing container, and determine a plurality of feature values for a plurality of features of the electronic message based on the retrieved data. The one or more processors can determine, based on the plurality of feature values, a likelihood of receiving a response from a receiving entity once the electronic message is sent to that receiving entity. The one or more processors can provide an indication of the determined likelihood of receiving a response and indications of the plurality of determined feature values for display in association with a message composing window displaying the text received.
    Type: Grant
    Filed: June 17, 2022
    Date of Patent: February 27, 2024
    Assignee: Baydin, Inc.
    Inventors: Aye Moah, Alexander Moore, Michael Chin
  • Publication number: 20240042036
    Abstract: Described herein is anhydrous sodium thiosulfate, methods for synthesizing anhydrous sodium thiosulfate, pharmaceutical compositions thereof, and methods of treating ototoxicity. Anhydrous sodium thiosulfate is synthesized from sodium sulfite, sulfur, and cetylpyridinium chloride. The anhydrous sodium thiosulfate is formulated into a pharmaceutical composition comprising a buffer and solvent. These compositions are useful for eliminating or reducing ototoxicity in pediatric patients receiving platinum-based chemotherapeutics.
    Type: Application
    Filed: September 29, 2023
    Publication date: February 8, 2024
    Applicant: Fennec Pharmaceuticals Inc
    Inventors: Thomas Claiborne Lovelace, Joseph Alexander Moore, III, Christopher McKinnon Lee, Daniel Logan Kirschner
  • Publication number: 20230201350
    Abstract: Described herein is anhydrous sodium thiosulfate, methods for synthesizing anhydrous sodium thiosulfate, pharmaceutical compositions thereof, and methods of treating ototoxicity. Anhydrous sodium thiosulfate is synthesized from sodium sulfite, sulfur, and cetylpyridinium chloride. The anhydrous sodium thiosulfate is formulated into a pharmaceutical composition comprising a buffer and solvent. These compositions are useful for eliminating or reducing ototoxicity in pediatric patients receiving platinum-based chemotherapeutics.
    Type: Application
    Filed: February 20, 2023
    Publication date: June 29, 2023
    Applicant: Fennec Pharmaceuticals Inc.
    Inventors: Thomas Claiborne Lovelace, Joseph Alexander Moore, III, Christopher McKinnon Lee, Daniel Logan Kirschner
  • Publication number: 20230201349
    Abstract: Described herein is anhydrous sodium thiosulfate, methods for synthesizing anhydrous sodium thiosulfate, pharmaceutical compositions thereof, and methods of treating ototoxicity. Anhydrous sodium thiosulfate is synthesized from sodium sulfite, sulfur, and cetylpyridinium chloride. The anhydrous sodium thiosulfate is formulated into a pharmaceutical composition comprising a buffer and solvent. These compositions are useful for eliminating or reducing ototoxicity in pediatric patients receiving platinum-based chemotherapeutics.
    Type: Application
    Filed: February 20, 2023
    Publication date: June 29, 2023
    Applicant: Fennec Pharmaceuticals Inc.
    Inventors: Thomas Claiborne Lovelace, Joseph Alexander Moore, III, Christopher McKinnon Lee, Daniel Logan Kirschner
  • Publication number: 20230201351
    Abstract: Described herein is anhydrous sodium thiosulfate, methods for synthesizing anhydrous sodium thiosulfate, pharmaceutical compositions thereof, and methods of treating ototoxicity. Anhydrous sodium thiosulfate is synthesized from sodium sulfite, sulfur, and cetylpyridinium chloride. The anhydrous sodium thiosulfate is formulated into a pharmaceutical composition comprising a buffer and solvent. These compositions are useful for eliminating or reducing ototoxicity in pediatric patients receiving platinum-based chemotherapeutics.
    Type: Application
    Filed: February 20, 2023
    Publication date: June 29, 2023
    Applicant: Fennec Pharmaceuticals Inc.
    Inventors: Thomas Claiborne Lovelace, Joseph Alexander Moore, III, Christopher McKinnon Lee, Daniel Logan Kirschner
  • Publication number: 20230158145
    Abstract: Described herein is anhydrous sodium thiosulfate, methods for synthesizing anhydrous sodium thiosulfate, pharmaceutical compositions thereof, and methods of treating ototoxicity. Anhydrous sodium thiosulfate is synthesized from sodium sulfite, sulfur, and cetylpyridinium chloride. The anhydrous sodium thiosulfate is formulated into a pharmaceutical composition comprising a buffer and solvent. These compositions are useful for eliminating or reducing ototoxicity in pediatric patients receiving platinum-based chemotherapeutics.
    Type: Application
    Filed: November 22, 2022
    Publication date: May 25, 2023
    Applicant: Fennec Pharmaceuticals Inc.
    Inventors: Thomas Claiborne Lovelace, Joseph Alexander Moore, III, Christopher McKinnon Lee, Daniel Logan Kirschner
  • Patent number: 11617793
    Abstract: Described herein is anhydrous sodium thiosulfate, methods for synthesizing anhydrous sodium thiosulfate, pharmaceutical compositions thereof, and methods of treating ototoxicity. Anhydrous sodium thiosulfate is synthesized from sodium sulfite, sulfur, and cetylpyridinium chloride. The anhydrous sodium thiosulfate is formulated into a pharmaceutical composition comprising a buffer and solvent. These compositions are useful for eliminating or reducing ototoxicity in pediatric patients receiving platinum-based chemotherapeutics.
    Type: Grant
    Filed: July 22, 2022
    Date of Patent: April 4, 2023
    Assignee: Fennec Pharmaceuticals, Inc.
    Inventors: Thomas Claiborne Lovelace, Joseph Alexander Moore, III, Christopher Mckinnon Lee, Daniel Logan Kirschner
  • Publication number: 20230094842
    Abstract: Described herein is anhydrous sodium thiosulfate, methods for synthesizing anhydrous sodium thiosulfate, pharmaceutical compositions thereof, and methods of treating ototoxicity. Anhydrous sodium thiosulfate is synthesized from sodium sulfite, sulfur, and cetylpyridinium chloride. The anhydrous sodium thiosulfate is formulated into a pharmaceutical composition comprising a buffer and solvent. These compositions are useful for eliminating or reducing ototoxicity in pediatric patients receiving platinum-based chemotherapeutics.
    Type: Application
    Filed: November 22, 2022
    Publication date: March 30, 2023
    Applicant: Fennec Pharmaceuticals Inc.
    Inventors: Thomas Claiborne Lovelace, Joseph Alexander Moore, III, Christopher McKinnon Lee, Daniel Logan Kirschner
  • Publication number: 20230094886
    Abstract: Described herein is anhydrous sodium thiosulfate, methods for synthesizing anhydrous sodium thiosulfate, pharmaceutical compositions thereof, and methods of treating ototoxicity. Anhydrous sodium thiosulfate is synthesized from sodium sulfite, sulfur, and cetylpyridinium chloride. The anhydrous sodium thiosulfate is formulated into a pharmaceutical composition comprising a buffer and solvent. These compositions are useful for eliminating or reducing ototoxicity in pediatric patients receiving platinum-based chemotherapeutics.
    Type: Application
    Filed: November 22, 2022
    Publication date: March 30, 2023
    Applicant: Fennec Pharmaceuticals Inc.
    Inventors: Thomas Claiborne Lovelace, Joseph Alexander Moore, III, Chirstopher McKinnon Lee, Daniel Logan Kirschner
  • Publication number: 20230081134
    Abstract: Systems and methods for dynamically assessing and displaying quality features of electronic messages, while composed on client devices, can include one or more processors monitoring the process of composing the electronic message. The one or more processors can retrieve, upon detecting a pause event, data associated with the composed electronic message from a message composing container, and determine a plurality of feature values for a plurality of features of the electronic message based on the retrieved data. The one or more processors can determine, based on the plurality of feature values, a likelihood of receiving a response from a receiving entity once the electronic message is sent to that receiving entity. The one or more processors can provide an indication of the determined likelihood of receiving a response and indications of the plurality of determined feature values for display in association with a message composing window displaying the text received.
    Type: Application
    Filed: June 17, 2022
    Publication date: March 16, 2023
    Applicant: Baydin, Inc.
    Inventors: Aye Moah, Alexander Moore, Michael Chin
  • Publication number: 20230031878
    Abstract: A system is provided which that allows users of electronic communication systems and/or calendar systems the ability to suggest meetings to users of different electronic communication systems and/or calendar systems via electronic messages. The system may provide users with the ability to share calendar availability with users of other electronic communication systems and/or calendar systems via electronic message. One aspect of the disclosed system is the fact that users can share interactive calendar information, and propose and confirm tentative meetings and events, with users of different electronic communications and/or calendar systems. Additionally, calendar information that is shared with others may be dynamically updated even after the electronic messages have been sent.
    Type: Application
    Filed: April 27, 2022
    Publication date: February 2, 2023
    Applicant: Baydin, Inc.
    Inventors: Alexander Moore, Michael CHIN, Aye Moah, Alexey Komissarouk
  • Publication number: 20220378915
    Abstract: Described herein is anhydrous sodium thiosulfate, methods for synthesizing anhydrous sodium thiosulfate, pharmaceutical compositions thereof, and methods of treating ototoxicity. Anhydrous sodium thiosulfate is synthesized from sodium sulfite, sulfur, and cetylpyridinium chloride. The anhydrous sodium thiosulfate is formulated into a pharmaceutical composition comprising a buffer and solvent. These compositions are useful for eliminating or reducing ototoxicity in pediatric patients receiving platinum-based chemotherapeutics.
    Type: Application
    Filed: July 22, 2022
    Publication date: December 1, 2022
    Applicant: Fennec Pharmaceuticals Inc.
    Inventors: Thomas Claiborne Lovelace, Joseph Alexander Moore, III, Christopher McKinnon Lee, Daniel Logan Kirschner
  • Patent number: 11510984
    Abstract: Described herein is anhydrous sodium thiosulfate, methods for synthesizing anhydrous sodium thiosulfate, pharmaceutical compositions thereof, and methods of treating ototoxicity. Anhydrous sodium thiosulfate is synthesized from sodium sulfite, sulfur, and cetylpyridinium chloride. The anhydrous sodium thiosulfate is formulated into a pharmaceutical composition comprising a buffer and solvent. These compositions are useful for eliminating or reducing ototoxicity in pediatric patients receiving platinum-based chemotherapeutics.
    Type: Grant
    Filed: June 24, 2022
    Date of Patent: November 29, 2022
    Assignee: Fennec Pharmaceuticals, Inc.
    Inventors: Thomas Claiborne Lovelace, Joseph Alexander Moore, III, Christopher McKinnon Lee, Daniel Logan Kirschner